World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
32515
World Ranking
16924
National Ranking
8489

Jonathan G. Goldin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jonathan G. Goldin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 371 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jonathan G. Goldin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jonathan G. Goldin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jonathan G. Goldin is affiliated with the University of California, Los Angeles in the United States. Their research primarily spans the field of Medicine, with a focus on Pulmonary and Respiratory Medicine, where they have contributed extensively.

Their work covers several subfields, including Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Epidemiology, and Critical Care and Intensive Care Medicine.

The main topics Jonathan G. Goldin has explored include:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Systemic Sclerosis and Related Diseases
  • Medical Imaging and Pathology Studies
  • Inflammatory Myopathies and Dermatomyositis
  • Lung Cancer Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • COVID-19 diagnosis using AI

Among recent papers associated with or relevant to their field, the following stand out:

  • The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic, 2020, CHEST Journal
  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, The Lancet Respiratory Medicine
  • Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease, 2021, Arthritis & Rheumatology
  • Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial, 2021, American Journal of Respiratory and Critical Care Medicine
  • Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency, 2024, American Journal of Respiratory and Critical Care Medicine

Jonathan G. Goldin has frequently published in notable venues, including:

  • American Journal of Respiratory and Critical Care Medicine
  • Medical Physics
  • Annals of the Rheumatic Diseases
  • CHEST Journal
  • Neuro-Oncology

Their frequent co-authors include:

  • Grace Hyun J. Kim
  • Elizabeth R. Volkmann
  • Donald P. Tashkin
  • Michael D. Roth
  • Fereidoun Abtin

Best Publications

  • Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis

    William G. Goodman;Jonathan Goldin;Beatriz D. Kuizon;Chun Yoon

  • Assessment of coronary artery disease by cardiac computed tomography : A scientific statement from the american heart association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, council on clinical cardiology

    Matthew J. Budoff;Stephan Achenbach;Roger S. Blumenthal;J. Jeffrey Carr

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society

    Geoffrey D. Rubin;Christopher J. Ryerson;Linda B. Haramati;Nicola Sverzellati

  • Chronic obstructive pulmonary disease phenotypes: the future of COPD.

    Mei Lan K. Han;Alvar Agusti;Peter M. Calverley;Bartolome R. Celli

  • The national lung screening trial: Overview and study design

    Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  • A randomized study of endobronchial valves for advanced emphysema.

    Frank C. Sciurba;Armin Ernst;Felix J.F. Herth;Charlie Strange

  • Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.

    David A Lynch;Nicola Sverzellati;William D Travis;Kevin K Brown

  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

    K. M. Sullivan;E. A. Goldmuntz;L. Keyes-Elstein;P. A. McSweeney

  • Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Michael D. Roth

  • Accuracy of PET/CT in Characterization of Solitary Pulmonary Lesions

    Shanna K Kim;Martin Allen-Auerbach;Jonathan Goldin;Barbara J Fueger

  • Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.

    Whitney B Pope;Hyun J Kim;Jing Huo;Jeffry Alger

  • Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial

    P. L. Shah;D-J Slebos;P. F. G. Cardoso;E. Cetti

  • High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease

    Jonathan G. Goldin;David A. Lynch;Diane C. Strollo;Robert D. Suh

  • SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs

    Jered P. Sieren;John D. Newell;R. Graham Barr;Eugene R. Bleecker

  • A pattern classification approach to characterizing solitary pulmonary nodules imaged on high resolution CT: preliminary results.

    Michael F. McNitt-Gray;Eric M. Hart;Nathaniel Wyckoff;James W. Sayre

  • Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: Assessment with functional helical thin-section computed tomography

    Jonathan G. Goldin;Donald P. Tashkin;Eric C. Kleerup;Lloyd E. Greaser

  • Patient-specific models for lung nodule detection and surveillance in CT images

    M.S. Brown;M.F. McNitt-Gray;J.G. Goldin;R.D. Suh

Frequent Co-Authors

Donald P. Tashkin
Donald P. Tashkin University of California, Los Angeles
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
James Sayre
James Sayre University of California, Los Angeles
Robert Elashoff
Robert Elashoff University of California, Los Angeles
Philip J. Clements
Philip J. Clements University of California, Los Angeles
David A. Lynch
David A. Lynch Children's Hospital of Philadelphia
Virginia D. Steen
Virginia D. Steen Georgetown University
John A. Belperio
John A. Belperio University of California, Los Angeles
Athol U. Wells
Athol U. Wells Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine opens up a variety of related fields and online learning opportunities. Those interested in healthcare management may consider health administration degrees online, which prepare students for leadership roles across hospitals, clinics, and insurance companies.

For professionals seeking advanced qualifications, a master's in healthcare administration online can offer greater career flexibility and a path to executive positions in the growing healthcare sector. These programs can often be completed entirely online, making them accessible for working adults.

Practicing registered nurses looking to further their expertise might explore some of the cheapest dnp (Doctor of Nursing Practice) programs. This terminal degree can expand opportunities in clinical practice, leadership, and education.

Finally, students interested in medication management and pharmaceutical sciences may consider pursuing accredited pharmd online programs. These degrees equip graduates for diverse roles in pharmacies, hospitals, research centers, and the pharmaceutical industry.

Best Scientists Citing Jonathan G. Goldin

Trending Scientists

Recently Published Articles